These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 7891351)
1. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. Joseph DB; Bidlack JM J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351 [TBL] [Abstract][Full Text] [Related]
2. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein. Lawrence DM; Bidlack JM J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800 [TBL] [Abstract][Full Text] [Related]
3. Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling. Lawrence DM; Joseph DB; Bidlack JM Biochem Pharmacol; 1995 Jan; 49(1):81-9. PubMed ID: 7840787 [TBL] [Abstract][Full Text] [Related]
4. Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity. Martin-Kleiner I; Bidlack JM Int Immunopharmacol; 2001 Jan; 1(1):13-20. PubMed ID: 11367510 [TBL] [Abstract][Full Text] [Related]
5. Differential agonist regulation of the human kappa-opioid receptor. Blake AD; Bot G; Li S; Freeman JC; Reisine T J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509 [TBL] [Abstract][Full Text] [Related]
6. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330 [TBL] [Abstract][Full Text] [Related]
7. kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments. Avidor-Reiss T; Zippel R; Levy R; Saya D; Ezra V; Barg J; Matus-Leibovitch N; Vogel Z FEBS Lett; 1995 Mar; 361(1):70-4. PubMed ID: 7890042 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192 [TBL] [Abstract][Full Text] [Related]
9. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition. Shukla VK; Turndorf H; Bansinath M Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869 [TBL] [Abstract][Full Text] [Related]
10. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands. de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008 [TBL] [Abstract][Full Text] [Related]
11. Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes. Konkoy CS; Childers SR Biochem Pharmacol; 1993 Jan; 45(1):207-16. PubMed ID: 8381004 [TBL] [Abstract][Full Text] [Related]
12. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor. Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes. Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart. Zhang WM; Wang HX; Xia Q; Wong TM Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688 [TBL] [Abstract][Full Text] [Related]
15. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts. Xia Q; Sheng JZ; Tai KK; Wong TM J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007 [TBL] [Abstract][Full Text] [Related]
16. Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein. Ozawa T; Nakagawa T; Minami M; Satoh M Neurosci Lett; 1999 May; 267(2):117-20. PubMed ID: 10400226 [TBL] [Abstract][Full Text] [Related]
17. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034 [TBL] [Abstract][Full Text] [Related]
18. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors. Yu XC; Li HY; Wang HX; Wong TM J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017 [TBL] [Abstract][Full Text] [Related]
19. Sensitization of the adenylyl cyclase system in cloned kappa-opioid receptor-transfected cells following sustained agonist treatment: A chimeric study using G protein alpha(i)2/alpha(q) subunits. Nakagawa T; Ozawa T; Watanabe T; Minami M; Satoh M Jpn J Pharmacol; 1999 Dec; 81(4):353-61. PubMed ID: 10669040 [TBL] [Abstract][Full Text] [Related]